Screener
Insight Molecular Diagnostics Inc. IMDX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$11.26M-15.6% | -$4.29M+35.7% | -$22.96M+31.5% | -$10.85M+19.6% | -$9.74M-115% | ||
| $665K+19.0% | $631K+30.4% | $563K+4.1% | $584K+83.6% | $559K+83.9% | ||
| $661K+31.2% | $615K+30.0% | $721K+44.5% | $521K+15.8% | $504K+30.6% | ||
| -$9.27M-50.1% | -$7.64M-30.8% | -$5.55M-3.6% | -$4.63M+16.3% | -$6.17M-3.3% | ||
| $779K+123% | $613K+99.7% | $1.48M+591% | $1.05M+1,107% | $349K+82.7% | ||
| -$779K-123% | -$613K-99.7% | -$1.48M-604% | -$1.05M-1,107% | -$349K-82.7% | ||
| —— | $24.7M-13.5% | —— | —— | —— | ||
| —— | $16.44M-26.6% | —— | —— | —— | ||
| -$10.05M-54.0% | -$8.25M-34.3% | -$7.02M-26.2% | -$5.68M-1.1% | -$6.52M-5.7% |
FAQ
- How much cash does Insight Molecular Diagnostics Inc. generate?
- Insight Molecular Diagnostics Inc. (IMDX) generated -$27.1M in operating cash flow over the trailing twelve months.
- What is Insight Molecular Diagnostics Inc.'s free cash flow?
- After $3.9M of capital expenditures, Insight Molecular Diagnostics Inc.'s free cash flow was -$31.0M over the trailing twelve months, down 30.0% year over year.
- Where does Insight Molecular Diagnostics Inc.'s cash flow data come from?
- Every line is extracted from Insight Molecular Diagnostics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
